Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country
Application Due Date
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date
NSCLC Biomarker Testing
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology Andorra, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, Spain, Sweden, Switzerland, USA, United Kingdom
Development of Talazoparib for Prostate Cancer
Release Date:
Partner: National Comprehensive Cancer Network
Review Process: Expert Review Panel
Research Oncology USA
Approaches to Smoking Cessation Counseling
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine Australia, India, Japan, New Zealand, Singapore, Taiwan
Burden of Community Acquired Pneumonia
Release Date:
Review Process: Pfizer Internal
Research Vaccines USA
Closing Knowledge Gaps in Moderate-to-Severe Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Progress in Androgen Deprivation Therapy (ADT) in Advanced Prostate Cancer
Release Date:
Partner: Myovant Sciences
Review Process: Pfizer Internal
Education Oncology USA
Efforts to Promote Team-based Care and Regional Medical Collaboration for Cancer Patients
Release Date:
Partner: Japan Society of Clinical Oncology
Review Process: Expert Review Panel
Quality Improvement Oncology Japan
ISID-Pfizer 2021 Grant Challenge
Release Date:
Partner: The International Society for Infectious Diseases (ISID)
Review Process: Expert Review Panel
Quality Improvement Hospital All
Hemophilia: Improve Knowledge Level of Gene Therapy
Release Date:
Review Process: Pfizer Internal
Education Rare Disease Japan
China Medical Education in Breast Cancer Diagnosis and Treatment
Release Date:
Review Process: Pfizer Internal
Education Oncology China
Data generation on the treatment of Metastatic Breast Cancer with CDK 4/6 inhibitors
Release Date:
Review Process: Expert Review Panel
Research Oncology Portugal
Understanding Healthcare disparities in IBD Patients in Underserved Communities
Release Date:
Review Process: Pfizer Internal
Quality Improvement Inflammation & Immunology Canada, USA